Significant Ownership of Frazier Life Sciences Public Fund, L.P.

Signature - Title
/s/ Steve R. Bailey - By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P., GP of Frazier Life Sciences Public Fund, L.P.
Location
Palo Alto, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Frazier Life Sciences Public Fund, L.P..

Notify me when Frazier Life Sciences Public Fund, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Frazier Life Sciences Public Fund, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ADVM ADVERUM BIOTECHNOLOGIES, INC. Common Stock, $0.0001 par value per share 19.4% $17.5M $12.9M 4.29M +280% Frazier Life Sciences Public Fund, L.P. Nov 25, 2025
MBX MBX BIOSCIENCES, INC. Common Stock, $0.0001 par value per share 11.7% $72.6M $9.26M 5.22M +14.6% Patrick J. Heron Sep 26, 2025
XLO Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.9% $5.62M $1.65M 8.14M +41.7% Frazier Life Sciences Public Fund, L.P. Jun 30, 2025
PHAT PHATHOM PHARMACEUTICALS, INC. Common Stock, $0.0001 par value per share 8.6% $70.4M 5.99M 0% James N. Topper Nov 1, 2025
NAMS NEWAMSTERDAM PHARMA COMPANY N.V. Ordinary Shares, nominal value EUR0.12 per share 7.7% $245M $36.9M 8.62M +17.7% Frazier Life Sciences Public Fund, L.P. Nov 1, 2025
MAZE Maze Therapeutics, Inc. Common Stock - par value $0.001 per share 7.7% $46.5M -$15.2M 3.35M -24.7% Frazier Life Sciences Public Fund, L.P. Jun 30, 2025
TRVI Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share 7% $77.8M -$16M 8.51M -17.1% Frazier Life Sciences Public Fund, L.P. Sep 30, 2025
KALV KALVISTA PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share 6.9% $42.2M $13M 3.47M +44.4% Frazier Life Sciences Public Fund, L.P. Nov 1, 2025
LXEO Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share 5.7% $14.5M 3.07M Frazier Life Sciences Public Fund, L.P. Jun 30, 2025
ERAS Erasca, Inc. Common Stock, $0.0001 par value per share 5.3% $23.8M -$11.9M 15M -33.4% Frazier Life Sciences Public Fund, L.P. Jun 30, 2025
AURA Aura Biosciences, Inc. Common Stock, $0.00001 par value per share 5% $20.2M -$20.8M 3.11M -50.7% Frazier Life Sciences Public Fund, L.P. Jun 30, 2025
PVLA Palvella Therapeutics, Inc. Common Stock, $0.001 par value per share 4.9% $28M -$7.41M 546K -20.9% Frazier Life Sciences Public Fund, L.P. Jun 30, 2025
JBIO JADE BIOSCIENCES, INC. Common Stock, $0.0001 par value per share 4.2% $11.9M $379K 1.38M +3.28% Frazier Life Sciences Public Fund, L.P. Sep 30, 2025
MREO Mereo BioPharma Group plc Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares 4.1% $56.8M -$13.9M 32.4M -19.6% Frazier Life Sciences Public Fund, L.P. Jun 30, 2025
SVRA Savara Inc. Common Stock, par value $0.001 per share 3.9% $22.2M -$15.5M 6.75M -41.2% Frazier Life Sciences Public Fund, L.P. Jun 30, 2025
IRON DISC MEDICINE, INC. Common Stock, par value $0.0001 per share 3% $61.3M 1.03M Frazier Life Sciences Public Fund, L.P. Jun 30, 2025
MGNX MACROGENICS, INC. Common Stock, par value $0.01 per share 2.5% $2.23M 1.55M Frazier Life Sciences Public Fund, L.P. Jun 30, 2025
ORIC ORIC Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 2% $6.94M 1.41M James N. Topper Mar 31, 2025
ELDN Eledon Pharmaceuticals, Inc. Common Stock 2% $3.33M 1.18M James N. Topper Dec 31, 2024
ANAB AnaptysBio, Inc. Common Stock 0.5% Frazier Life Sciences Public Fund, L.P. Jan 31, 2025
ANTX AN2 THERAPEUTICS, INC. Common Stock 0% $0 0 Frazier Life Sciences Public Fund, L.P. Dec 31, 2024
PBYI Puma Biotechnology, Inc. Common Stock 0% $0 0 Frazier Life Sciences Public Fund, L.P. Dec 31, 2024
HLVX HILLEVAX, INC. Common Stock, par value $0.0001 per share 0% $0 0 Frazier Life Sciences Public Fund, L.P. Sep 17, 2025
ELEV Elevation Oncology, Inc. Common stock, par value $0.0001 per share 0% $0 0 Frazier Life Sciences Public Fund, L.P. Jul 23, 2025

Schedules 13D/G Reported by Frazier Life Sciences Public Fund, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.